Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
life sciences
novartis
3
×
boston top stories
clinical trials
gene therapy
national
national blog main
national top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
spinal muscular atrophy
zolgensma
abbvie
actavalon
acute myeloid leukemia
adaptive biotechnologies
aileron therapeutics
alicrocumab
american academy of neu
american academy of neurology
aprea therapeutics
arimoclomol
arnold levine
baker brothers
bicycle therapeutics
biogen
bioinnovation capital
biolabs
biopharma
biotech ipos
board of directors
boehringer ingelheim
boston
bostongene
boulder/denver blog main
boulder/denver top stories
What
public
3
×
healthcare
ipo
life
america
bio
biogen
biotech
blood
broader
cancer
company
continues
convoluted
democrats
detect
developing
dreams
driving
drug
files
firms
good
grail
head
headaches
history
holding
improved
industry
innovation
innovations
insurance
intended
investment
investors
join
long
medical
moves
Language
unset
Current search:
novartis
×
public
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
